Current Drug Therapy for Parkinson??s Disease
- 1 January 1992
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 2 (2), 112-124
- https://doi.org/10.2165/00002512-199202020-00005
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- SelegilineDrugs & Aging, 1991
- PergolideDrugs, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Reappraisal of Temporary Levodopa Withdrawal (Drug Holiday) in Parkinson's DiseaseNew England Journal of Medicine, 1985
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal of Neural Transmission, 1985
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- DomperidoneDrugs, 1982
- Anticholinergic and membrane activities of amantadine in neuromuscular transmissionNature, 1976
- ParkinsonismNeurology, 1967